Arthneeti
Solar IndustriesQ1 FY26

Solar Industries Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹19,430P/E: 88.3Market Cap: ₹1.8L CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

No information is provided regarding the same in the latest conference call.

See what Solar Industries management said on margin guidance — free account, 30 seconds.

Fundraise plans

No information is provided regarding the same in the latest conference call.

See what Solar Industries management said on order book — free account, 30 seconds.

Capex plans

No information is provided regarding the same in the latest conference call.

Track Solar Industries — get its next earnings analysis in your feed

How does Solar Industries rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisSolar Industries
See where Solar Industries sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Solar Industries rank in Chemicals & Petrochemicals?

Compare Solar Industries against every Chemicals & Petrochemicals company (Q1 FY26) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Continue your research

What Solar Industries's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

  • Neochem Bio Solutions Ltd (Q2 FY27)

    Revenue from Operations for H1 FY27: ₹68.9 crores, up 50% YoY (from ₹45.8 crores in H1 FY26) [Page 22] . Key investor presentation takeaways from Neochem Bio So

Compare:vs Pidilite Inds.vs SRF Ltdvs Linde India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →